
²úÆ··ÖÀà
CLASSIFICATION
Ïà¹ØÎÄÕÂ
RELATED ARTICLES2026-07-13
2026-07-08
2026-06-15
2026-06-11
2026-05-22
2026-05-19
2026-05-19
2026-05-08
2026-04-20
2026-04-15
ÈËÔ´ÒÒõ£»¯¸ßÃܶÈÖ¬µ°°×»ù±¾ÐÅÏ¢ ²úÆ·±àºÅ£ºPC0298 Ó¢ÎÄÃû£ºHuman Ac-HDL (Human Acetylated High Density Lipoprotein) ÔËÊäÌõ¼þ£º2-8¡æ
ºìɫӫ¹â±ê¼ÇÈËÔ´¸ßÃܶÈÖ¬µ°°×»ù±¾ÐÅÏ¢ ²úÆ·±àºÅ£ºPC0297 Ó¢ÎÄÃû£ºHuman DiI-HDL (Human DiI-High Density Lipoprotein) ÔËÊäÌõ¼þ£º2-8¡æ
Ö¬µ°°×ÔÚÈËÌåÖÐÖ÷ÒªÆðµ½ÔËÊäÖ¬ÖÊ£¨ÈçÖ¬ÖÊ¡¢¸ÊÓÍÈýõ¥£©µÄ×÷Ó㬰´ÕÕ·Ö×ÓÁ¿´óС£¬Ö÷Òª·ÖΪÒÔϼ¸ÖÖ£¨´Ó¸ßµ½µÍ£©£ºÈéÃÓ£¨CM£©¡¢¼«µÍÃܶÈÖ¬µ°°× (VLDL)¡¢ÖмäÃܶÈÖ¬µ°°× (IDL)¡¢µÍÃܶÈÖ¬µ°°× (LDL)¡¢¸ßÃܶÈÖ¬µ°°×£¨HDL£©µÈ¡£
ÖÐÎÄÃû³Æ£ºÑª¹Ü½ôÕÅËØ£¨1-7£© CASºÅ£º51833-78-4 ÖÐÎıðÃû£ºACEÒÖÖÆ¼Á(ANGIOTENSIN1-7);Ѫ¹Ü½ôÕÅËØ(1-7),98%;Ѫ¹Ü½ôÕÅËØ(1-7);»¯ºÏÎïANGIOTENSIN1-7;»¯ºÏÎïLY2584702TOSYLATE;1-7Ѫ¹Ü½ôÕÅËØ(1-7)
ÖÐÎÄÃû³Æ£ºÈËѪ¹Ü½ôÕÅËØIII CASºÅ£º12687-51-3 ÖÐÎıðÃû£ºÈËѪ¹Ü½ôËõËØII´×ËáÑÎË®ºÏÎï;Ѫ¹Ü½ôËõËØIII;[ILE7]-Ѫ¹Ü½ôÕÅËØIIIÒÒËáÑÎË®ºÏÎï;[ILE7]-Ѫ¹Ü½ôÕÅËØIIIÒÒËáÑÎË®ºÏÎï,¡Ý9Chemicalbook5%(HPLC);Ѫ¹Ü½ôÕÅËØIII,¡Ý98.0%(HPCE);»¯ºÏÎïT10322;Ѫ¹Ü½ôËõËØIII/Ѫ¹Ü½ôÕÅËØIII;Ѫ¹Ü½ôÕÅËØIIITFA
ÖÐÎÄÃû³Æ£ºÈËѪ¹Ü½ôÕÅËØII CASºÅ£º4474-91-3 ÖÐÎıðÃû£ºÑª¹Ü½ôÕÅëÄII;Ѫ¹Ü½ôÕÅëÄõ£°·;ÔöÑªÑ¹ËØ,HYPERTENSIN;Ѫ¹Ü½ôÕÅËØ2;Ôö¼ÓÑ¹ËØ;Ѫ¹Ü½ôÕÅËØII|ANGIOChemicalbookTENSINII|ANGIOTENSINII,HUMAN;ANGIOTENSINIIѪ¹Ü½ôÕÅËØ¢ò;Ѫ¹Ü½ôÕÅËØII(ÈË)
MBP£¬Ó¢ÎÄÈ«ÃûMyelin Basic Protein£¬ÖÐÎÄÃûËèÁ×Ö¬¼îÐÔµ°°×£¬Êǹ¹³ÉÖÐÊàÉñ¾ÏµÍ³£¨CNS£©ËèÁ×Ö¬µÄÖØÒª³É·Ö£¬ÓÉÉÙÍ»½ºÖÊϸ°ûºÍÊ©Íòϸ°û£¨Schwann cells£©ºÏ³É£¬¿ÉÓÃ×÷ÕâÁ½ÖÖϸ°ûµÄ±ê¼ÇÎï¡£MBPÊÇÒ»Ìõµ¥Á´¶àëÄ£¬·Ö×ÓÁ¿Ô¼18.5kDa£¬Î»ÓÚÖÂÃܵÄËèÇʺÍËèºËÖС£ÊÇÒ»ÖÖÓÐDZÁ¦µÄ°ÐÏò¿¹Ô£¬Äܹ»ÓÕ·¢¶¯Îï²úÉúʵÑéÐÔ¹ýÃôÐÔÄÔ¼¹ËèÑ×£¨EAE£©¡£
ÂÑÇå°×µ°°×¶àëÄ£¨323-339£©»ù±¾ÐÅÏ¢ ²úÆ·±àºÅ£ºPC0286 Ó¢ÎÄÃû£ºOVA Peptide (323-339) ±ðÃû£ºÂÑÇå°×µ°°×¶àëÄ£¨323-339£© CAS No.£º92915-79-2 ÔËÊäÌõ¼þ£º-20¡æ